Sialic acid

Other Names

2-keto-5-acetamido-3,5-dideoxy-D-glycero-D-galactononulopyranos-1-onic acid5-Acetamido-3,5-dideoxy-D-glycero-D-galacto-nonulopyranosonic acid5-Acetamido-3,5-dideoxy-D-glycero-D-galactononulosonic acid5-N-Acetyl-D-neuraminic acid5-N-Acetylneuraminic acidAceneuramic acidAcetylneuraminic acidD-glycero-D-galacto-2-Nonulosonic acid, 5-(acetylamino)-3,5-dideoxy-Gynaminic acidHemataminic acidKohlenhydrat ILactaminic acidLactiminic acidN-Acetyl-beta-neuraminic acidN-Acetyl-D-neuraminic acidN-Acetylneuramic acidN-Acetylneuraminic acidN-Acetylsialic acidNANNANANeu5AcNeuAcNeuNAcNeuraminic acidO-sialic acid

Synopsis

Sialic Acid

1. Identity, Chemical Names, and Common Forms

Sialic acid (SA) is the generic name for a family of acidic, nine-carbon monosaccharides that share a common backbone derived from neuraminic acid. Sialic acids are a family of α-keto acids with a nine-carbon backbone, and more than 50 sialic acid forms have been found in nature, including the most abundant N-acetylneuraminic acid (Neu5Ac), the non-human N-glycolylneuraminic acid (Neu5Gc), 2-keto-3-deoxy-nonulosonic acid (KDN, also called deaminoneuraminic acid), and their various O-methyl, O-lactyl, O-sulfo, O-phospho-, and single or multiple O-acetyl derivatives.

Sialic acid is a member of the nine-carbon monosaccharides with a keto acid functional group. It is ubiquitous across vertebrate tissues. It was first isolated by Blix et al. from submaxillary mucin in 1936 and named "sialic acid" due to its acidic nature and its origin from saliva.

N-acetylneuraminic acid (Neu5Ac), termed "sialic acid" in common usage, is one of over thirty known sialic acid analogs. It is the predominant form of sialic acid in humans and is presented as the terminal residue on surface-exposed glycans, glycoproteins, and glycolipids. N-Acetylneuraminic acid (Neu5Ac), the most common type of sialic acid, generally acts as the terminal sugar in cell surface glycans, glycoconjugates, oligosaccharides, lipo-oligosaccharides, and polysaccharides, thus exerting numerous physiological functions.

Neu5Gc is produced from Neu5Ac by the activity of cytidine 5'-monophosphate-N-acetylneuraminic acid hydroxylase (CMAH) in the cytoplasm of cells, and this enzyme is missing or inactive in some animals, including humans. In humans, the basis for this phenotype is a fixed loss-of-function mutation of the cytidine monophosphate N-acetylneuraminic acid hydroxylase (CMAH) gene, which remains intact in the closest evolutionary relatives — chimpanzees.

Common Forms and Preparations

Free sialic acid: The monosaccharide in its unbound form; found only in small proportions in natural sources and body fluids.
Protein-bound sialic acid (glycoproteins): As a traditional Chinese health food, edible bird's nest (EBN) has high medicinal value, which is mostly attributed to the high content of sialic acid (SA). SA mainly exists in protein-bound, oligosaccharide-bound, and free forms, and the binding forms of SA are closely related to the functions of EBN.
Oligosaccharide-bound sialic acid (sialylated HMOs): Over 200 distinct types of human milk oligosaccharides (HMOs) have been characterized, with approximately 70–75% being neutral HMOs and 10–30% being sialylated HMOs, distinguished by the presence of a sialic acid molecule at the terminal position.
Ganglioside-bound sialic acid: Sialic acid esterified to ceramide-based glycolipids (gangliosides) on neuronal cell surfaces; a structurally distinct and neurologically critical form.
Polysialic acid (polySia): A major protein-bound sialoglycan in the brain is polysialic acid (polySia), a linear homopolymer of α2–8-linked sialic acid residues, predominantly linked to the neural cell adhesion molecule (NCAM).
Isolated / supplemental Neu5Ac: Neu5Ac can be isolated from edible bird's nest (EBN), mucins, milk, eggs, red meat, and some fish species. It is traditionally produced via extraction from natural sources or by chemical synthesis.

2. Natural Sources

Sialic acids have never been detected in plants and are found in large amounts primarily in vertebrates and in a few "higher" invertebrates. Among dietary sources, concentrations differ substantially by food type and form of sialic acid present.

Sialic acid is present in some daily dietary sources, particularly in conjugated form (sialoglycans), such as those in edible bird's nest, red meats, breast milk, bovine milk, and eggs. Among them, breast milk, especially colostrum, contains a high concentration of sialylated oligosaccharides.

Sialic acids are acidic monosaccharides and red meat is a notable dietary source of sialic acid for humans. Among the sialic acids, N-acetylneuraminic acid (Neu5Ac) and 2-keto-3-deoxy-D-glycero-D-galacto-2-nonulosonic acid (KDN) play multiple roles in immunity and brain cognition. On the other hand, N-glycolylneuraminic acid (Neu5Gc) is a non-human sialic acid capable of potentiating cancer and inflammation in the human body.

Regarding concentrations in human milk across the lactation period: the average concentration of sialic acid in colostrum, transition milk, and at 1 and 3 months postpartum were 1,670.74 ± 94.53, 1,272.19 ± 128.74, 541.64 ± 55.2, and 297.65 ± 20.78 mg/L, respectively. The total sialic acid concentration in colostrum was about 5.6 times higher than that at 3 months (P < 0.001).

Formula-fed infants obtain approximately 25% or less of the sialic acid delivered during exclusive breastfeeding; mature human milk contains approximately 0.7 g/L of sialic acid, while formula milk based on mature bovine milk contains 0–0.2 g/L. A majority of sialic acid (70%) present in formula milk is linked with glycoproteins, whereas in human milk, it is linked with human milk oligosaccharides (73%).

Sialic acid is a functional monosaccharide that exists widely in edible bird's nest, milk, meat, and mucous membrane surfaces. Sialic acid level varies depending on the source, where edible bird's nest (EBN), predominantly containing Neu5Ac, is among the major sources of sialic acid.

3. Traditional and Historical Use

The most extensively documented traditional use of a sialic acid-rich substance is that of edible bird's nest (EBN) in East and Southeast Asian traditions. The historical record of EBN for human consumption can be tracked back to about 1,500 years ago in China. Today, the consumption of EBN as food or as a medicinal product is very common in Asian populations.

The earliest recorded use of edible bird's nests as food dates back to the Tang dynasty, and today the consumption of edible bird's nests represents a culture passed down through the ages. As early as the Tang Dynasty, EBN was eaten and regarded as a symbol of status among ancient dignitaries. Chinese ancients believed that EBN had rich nutritional and pharmacological values and used it as traditional Chinese medicine.

Edible bird's nest is a nest constructed from the saliva secreted by several species of swiftlets in the family Apodidae, mixed with and bonded by their down feathers. It is primarily produced in Southeast Asian countries such as Malaysia, Indonesia, Thailand, and Myanmar, as well as in the coastal areas of Fujian and Guangdong in China. Edible bird's nest is rich in carbohydrates, organic acids, free amino acids, and its characteristic substance — sialic acid.

According to ancient literature, EBN is able to alleviate respiratory health conditions such as asthma, and is believed to have an impact on skin physiology. In traditional Chinese medicine (TCM), EBN was prepared by soaking the dried nest in water and simmering it, often with additional ingredients. In TCM, bird's nests are known to nourish yin energy, which represents coolness and moisture in the body. They are commonly prescribed for individuals experiencing dryness, digestive discomfort, or depleted yin. Bird nests' easy-to-digest composition makes them suitable for people with sensitive stomachs, providing gentle nourishment and healing.

Edible bird's nests have been an important part of China's health culture since ancient times, and they have been used for brain development and memory improvement for their antioxidant, anti-viral, anti-ageing, and anti-tumor properties and for their beneficial effects on the immune system, liver protection, and gut flora regulation.

It should be noted that the historical use of edible bird's nest preceded any understanding of sialic acid as a specific active compound; the attribution of benefits to sialic acid content specifically is a retrospective framing by modern researchers.

4. Key Constituents, Active Compounds, and Mechanisms of Action

4.1 Chemical Structure and Diversity

Sialic acids are a family of α-keto aldonic acids with a nine-carbon backbone. They are widely distributed in plants, animals, and microorganisms. More than 50 different types have been identified, and N-acetylneuraminic acid (Neu5Ac), N-glycolylneuraminic acid (Neu5Gc), and deaminoneuraminic acid (KDN) are the most abundant naturally occurring sialic acids.

Sialic acids are a family of negatively charged monosaccharides that are commonly presented as the terminal residues in glycans of the glycoconjugates on eukaryotic cell surfaces or as components of capsular polysaccharides or lipooligosaccharides of some pathogenic bacteria.

4.2 Biosynthesis and Metabolism

Sialic acid metabolism is regulated by sialyltransferases and sialidases. Sialyltransferases, located on the type II membrane protein of the Golgi apparatus, catalyze the transfer of sialic acid from a glycosyl donor CMP-Neu5Ac to the terminal positions of oligosaccharides and glycoconjugates. Sialyltransferases are categorized based on the position of sialic acid addition: β-galactoside α-2,3-sialyltransferases (ST3Gals), β-galactoside α-2,6-sialyltransferases (ST6Gals), and α-2,8-sialyltransferases (ST8Sia). Sialidases, or neuraminidases (NEU), mediate the desialylation process and are classified into four types: NEU1, NEU2, NEU3, and NEU4.

4.3 Mechanisms of Action

Many of the linear and branched glycans on cell surface glycoproteins and glycolipids of vertebrates are terminated with sialic acids — nine-carbon sugars with a carboxylic acid, a glycerol side-chain, and an N-acyl group that, along with their display at the outermost end of cell surface glycans, provide for varied molecular interactions. Among their functions, sialic acids regulate cell-cell interactions, modulate the activities of their glycoprotein and glycolipid scaffolds as well as other cell surface molecules, and are receptors for pathogens and toxins.

Multiple signaling pathways are implicated. Sialic acid is believed to work through the regulation of several signaling pathways, including GNE (UDP-N-acetyl-glucosamine-2-epimerase/N-acetylmannosamine kinase), polysialyltransferase-2,8-sialyltransferase IV, polysialic acid (PolySA), brain-derived neurotrophic factor (BDNF), mitogen-activated protein kinase (MAPK) signaling, nuclear factor-kappa B (NF-κB) pathway, Toll-like receptor 4 (TLR4) pathway, and nuclear factor erythroid 2-related factor 2 (Nrf2) pathway.

Immunological self-recognition: Sialic acid is recognized by immunoinhibitory sialic acid-binding immunoglobulin-like lectins (Siglecs) to prevent autoimmunity. Interestingly, select human pathogenic microbes have evolved to express this human sialic acid epitope on their own cellular surface to evade host immune surveillance and clearance.

Vascular function: The vascular endothelium's luminal surface is similarly rich in sialic acid residues, creating a charge repulsion that prevents erythrocyte adhesion and facilitates their unimpeded transit through the circulatory system.

Skin effects: Sialic acid enhances skin barrier function by upregulating filaggrin and its associated gene expression in keratinocytes, increasing stratum corneum hydration and reducing transepidermal water loss (TEWL). In terms of antioxidant effectiveness, sialic acid exhibits free radical scavenging capabilities, enhances antioxidant enzyme systems, and inhibits oxidative stress-related signaling pathways. Studies have confirmed that the application of sialic acid can significantly mitigate UV-induced oxidative stress-mediated cellular damage in both HaCaT cells and epitheliums.

Gut microbiota modulation: Sialic acid can modulate gut microbiota and metabolites, which affect gene expression and exert biological activities. Sialic acid can significantly alter the microbial community; it enhanced the presence of Prevotella and Lactobacillus species, and decreased the proportion of genera Escherichia/Shigella, Eubacterium, and Ruminococcus.

5. Scientific Evidence by Area of Use

5.1 Brain Development and Cognitive Function

Biological basis: Sialic acid is an essential component of brain gangliosides and the polysialic acid (polySia) chains that modify neural cell adhesion molecules (NCAM). Sialic acid levels are high in human breast milk, predominantly as N-acetylneuraminic acid (Neu5Ac). Sialic acid occurs in large amounts in human milk oligosaccharides and is an essential component of brain gangliosides and sialylated glycoproteins, particularly as precursors for the synthesis of the polysialic acid glycan that post-translationally modifies the cell membrane-associated neural cell adhesion molecules (NCAM).

The neural cell adhesion molecule (NCAM) is a glycoprotein implicated in cell-cell adhesion, neurite outgrowth, and synaptic plasticity. Polysialic acid (polySia) is mainly attached to NCAM and has an essential role in regulating NCAM-dependent developmental processes that require plasticity — namely, cell migration, axon guidance, and synapse formation.

Animal evidence (preclinical): The strongest experimental evidence for sialic acid and cognition comes from animal studies. Feeding a protein-bound source of sialic acid during early development enhanced learning and increased the expression of two genes associated with learning in developing piglets. In both tests, the supplemented groups learned in significantly fewer trials than did the control group, with a dose-response relation for the difficult task (P = 0.018). In the hippocampus, significant dose-response relations were observed between amount of sialic acid supplementation and mRNA levels of ST8SIA4 (P = 0.002) and GNE (P = 0.004), corresponding with proportionate increases in protein-bound sialic acid concentrations in the frontal cortex. Sialic acid in mammalian milks could play a role in cognitive development.

Polysialylated NCAM and neural gangliosides both play critical roles in mediating cell-to-cell interactions important for neuronal outgrowth, synaptic connectivity, and memory formation. A diet rich in sialic acid also increases the level of sialic acid in the brains of postnatal piglets, the expression level of two learning-related genes, and enhances learning and memory.

Human observational evidence: Breast-fed infants, when compared with formula-fed infants, were found to have almost two times more free sialic acid in saliva (mean ± SE: 16.0 ± 2.7 vs. 8.2 ± 2.1 mg/L, p < 0.036) and nearly 50% more total sialic acid (47.3 ± 3.9 vs. 32.2 ± 4.4 mg/L, p < 0.014). These findings provide a preliminary indication that an exogenous source of sialic acids derived from human milk may contribute to higher concentrations of sialic acid in body fluids. There are important implications for the formulation of human milk substitutes.

Evidence strength: Evidence for sialic acid's role in brain development is considered strong at the biochemical and mechanistic level, and robust in animal models. Controlled, interventional human clinical trials specifically testing isolated sialic acid supplementation and cognitive outcomes remain limited. Evidence that sialic acid from dietary sources can enhance cognitive performance in healthy adult humans has not been established in controlled trials.

5.2 Immune Function and Pathogen Interactions

In addition to their role in normal physiology, sialic acids are involved in the interaction of many pathogens with their host cells. Along with parasites and bacteria, a large number of viruses have been shown to interact with sialic acids for cellular attachment and entry. However, the specific sialic acid derivative that serves as the attachment receptor differs according to the virus strain and depends on the receptor binding site of the viral attachment protein.

Influenza A virus hemagglutinins from different virus strains showed consistently reduced binding to both Neu5Gc- and O-acetyl-modified sialic acids. The modifications of sialic acid in mucus may therefore have potent effects on the functions of influenza A virus and may affect both pathogens and the normal flora of different mucosal sites.

A small number of studies have reported anti-viral effects of EBN against influenza infections using in vitro and in vivo models, highlighting the importance of sialic acid and thymol derivatives in their therapeutic effects. Studies have reported that EBN suppresses the replicated virus from exiting the host cells, reduces viral replication, endosomal trafficking of the virus, intracellular viral autophagy, secretion of pro-inflammatory cytokines, reorientation of the actin cytoskeleton of infected cells, and increases the lysosomal degradation of viral materials.

Complex metazoans express a variety of sialic acid-binding immunoglobulin-like lectins (Siglecs) that preferentially bind different sialylated acceptors. A diverse population of sialic acids may thus facilitate cell-cell and cell-molecule interactions through direct or indirect cell signaling involving Siglec-sialoglycoconjugate interactions.

Evidence strength: The mechanistic role of sialic acid in viral binding and immune cell regulation is well-documented through in vitro and animal research. Direct human clinical trial evidence that dietary supplementation with sialic acid enhances immune outcomes in healthy or immunocompromised individuals is lacking. The antiviral data is primarily preclinical.

5.3 Infant Nutrition and Human Milk Oligosaccharides (HMOs)

Due to the immature development of the infant at birth, human milk is the primary source of sialic acid during infancy. Human milk-derived sialic acids are found most commonly as components of oligosaccharide chains, with about 69–76% as gangliosides and 21–28% as glycoproteins, while only 3% are found in the free form. Despite this, infant formulas contain less than 25% of the sialic acid concentration found in human milk, with infant formula compositions varying widely between commercial products.

Total sialic acid concentrations were highest in colostrum (5.04 ± 0.21 mmol/L in full-term) and decreased by nearly 80% over the next three months.

HMOs and bovine milk oligosaccharides have the ability to modulate the transcriptional response of colonic epithelial cells, increasing the level of expression of cell surface receptors, chemokines, and an epithelial cell-derived cytokine (IL-17C), and in this way may increase the protection of neonates, while also contributing to the maturation of the intestinal immune response.

Evidence strength: The disparity in sialic acid concentration between human breast milk and infant formula has been consistently demonstrated in human observational studies. Controlled interventional trials using sialic acid-enriched formulas in human infants and evaluating cognitive outcomes are limited, and larger randomized clinical trials are needed to confirm benefits.

5.4 Gut Microbiota Modulation

The consumption of sialic acids through dietary sources exerts significant influence on human health, possibly by modulating the gut microbiota's composition and metabolism.

There was a positive relation between breast milk Neu5Ac concentrations and low obesity risk of infants. Breast milk Neu5Ac modulated the infant gut microflora and bile acid metabolism. Parabacteroides may be associated with breast milk Neu5Ac levels. The gut microbiota may be a mediator between Neu5Ac and the growth of infants.

N-acetylneuraminic acid (Neu5Ac), the best-studied sialic acid, is a nutrient source for bacteria and, when displayed on the cell surface, a binding site for host immune factors, viruses, and bacterial toxins.

Evidence strength: Evidence for sialic acid's modulatory effects on gut microbiota is currently largely animal-based or observational in human infants. The causal relationship in humans remains an active area of investigation.

5.5 Cancer Biology and Serum Biomarker Use

Sialic acids are a family of acidic nine-carbon sugars typically located at the terminal residues of glycan chains on the vertebrate cellular glycocalyx and on secreted glycoproteins. Due to their prominent position on cell surfaces, sialic acids play a pivotal role in various pathological processes in cancer, including cell signaling, tumor dissociation, invasion, cell-matrix interactions, angiogenesis, immune modulation, and metastasis formation.

Serum sialic acid was found to be significantly greater in cancer patients than in normal individuals. Cancer patients with metastases had significantly greater serum sialic acid than cancer patients without metastases. In two cancer patients, sialic acid levels returned to normal after surgery. These findings are observational and reflect sialic acid as a potential biomarker of malignancy rather than a therapeutic agent.

Many sialyltransferases or sialidases have been found to express relatively higher or lower levels in tumors than in normal tissues. Sialic acids can be linked with other monosaccharides to form tremendously diversified sugar chains — sialic acids are often at the farthest end of antigens and glycoproteins. Among these antigens, some are very tumorigenic and widely occur among different tumors, such as sialyl Lewis X and A, which are known to positively correlate with colon and non-small cell lung cancer and core α6-fucosylation with liver and pancreatic cancer. Sialic acids in neoplasms might be a novel therapeutic target.

Evidence strength: The use of serum sialic acid as a cancer biomarker is supported by multiple observational human studies. Its use as a therapeutic target is supported principally by in vitro and animal data, with some early clinical pharmacology work. This area does not yet represent established clinical practice for supplementation.

5.6 Skin Health and Anti-Aging

Clinical evaluations demonstrated that a 56-day application of a sialic acid nanoliposome-containing cream resulted in a 4.20% increase in L* (skin lightness), 7.87% decrease in b* (yellowness), 8.45% decrease in transepidermal water loss (TEWL), and 4.01% reduction in wrinkle length, indicating superior brightening, barrier-repair, and anti-aging effects.

Despite these promising benefits, the application of sialic acid is hindered by its inherent limitations, including poor skin permeability, rapid degradation, and low bioavailability in conventional formulations.

In cultured SH-SY5Y (neuroblastoma) epithelial cell lines, the number of active mitochondria could be increased by 195% after the treatment with sialic acid. The possible use of EBN in treating Alzheimer's disease has been proposed based on these in vitro observations.

Evidence strength: Topical sialic acid for skin brightening and barrier repair has some early clinical evidence from small pilot studies. The systemic anti-aging claims are not well-supported by randomized controlled trials.

5.7 Antioxidant Activity

Sialic acid is an important functional component in promoting brain development, anti-oxidation, anti-inflammation, anti-virus, anti-tumor, and immune regulation. The antioxidant activity is mechanistically linked to free radical scavenging, modulation of the Nrf2 pathway, and protection of cells from oxidative stress as noted in in vitro models.

Evidence strength: Antioxidant data is primarily from cell-based (in vitro) experiments. Controlled human trials on sialic acid as an oral antioxidant supplement have not been published as of the time of this writing.

6. Body Systems and Health Areas Associated with Sialic Acid

Central nervous system: Sialic acids regulate cell-cell interactions, modulate the activities of their glycoprotein and glycolipid scaffolds as well as other cell surface molecules, and are receptors for pathogens and toxins. In the brain, two families of sialoglycans are of particular interest: gangliosides and polysialic acid.
Immune system: Sialic acid is an important functional component in promoting brain development, anti-oxidation, anti-inflammation, anti-virus, anti-tumor, and immune regulation.
Gastrointestinal tract: The intestinal mucosa covers the microbial community that has a significant impact on health. In the gut, sialic acid can also regulate gut microbiota and metabolites, participating in different biological functions.
Cardiovascular system: The vascular endothelium's luminal surface is rich in sialic acid residues, creating a charge repulsion that prevents erythrocyte adhesion and facilitates unimpeded transit through the circulatory system.
Skin: Sialic acid has been associated with skin barrier function, melanin suppression, and anti-aging through tyrosinase inhibition and filaggrin upregulation, as described in in vitro and pilot clinical evaluations.
Cancer biology: Elevated serum sialic acid serves as an observational biomarker for malignancy; sialylated antigens are implicated in tumor progression and immune evasion.

7. Dosage Forms and Reported Dosages in Studies

Sialic acid is encountered in multiple dosage forms across research contexts. It is important to note that standardized recommended dosages for supplemental sialic acid in humans have not been officially established by regulatory bodies. The following dosages are strictly those reported in published studies:

Infant nutritional context (human milk): The average concentration of sialic acid in colostrum was 1,670.74 ± 94.53 mg/L; at 3 months of lactation it had declined to 297.65 ± 20.78 mg/L.
Infant formula vs. human milk comparison: Mature human milk contains approximately 0.7 g/L of sialic acid, while formula milk based on mature bovine milk contains 0–0.2 g/L.
Sialyllactose supplementation in piglets (safety/efficacy study): No differences due to dietary treatment were observed for any outcome at the 4-week time-point. A treatment effect was observed for bound and total Neu5Ac in plasma (p = 0.022) for 8-week-old pigs, where control pigs had higher concentrations than either the 3′-SL or 6′-SL groups. No other differences were observed across Neu5Ac and Neu5Gc at the 8-week time-point.
Topical sialic acid (clinical skin study): A 56-day application of a sialic acid nanoliposome-containing cream was evaluated in a clinical setting, resulting in measurable changes in skin brightness, barrier function, and wrinkle parameters. Specific concentration of sialic acid in the formulation was not disclosed in the search results retrieved.
Edible bird's nest (dried equivalent): Pilot research cited in the literature references dried bird's nest intake, with EBN being the primary commercial supplemental vehicle for sialic acid consumption in Asian markets.

8. Safety Considerations and Notable Interactions

8.1 Neu5Gc: The Non-Human Sialic Acid and Human Health Implications

One of the most scientifically significant safety considerations around dietary sialic acid involves the distinction between Neu5Ac (the human form) and Neu5Gc (the non-human form found in red meat).

Neu5Gc is notable for its deficiency in humans due to a species-specific and universally inactivating deletion in the CMAH gene encoding the hydroxylase that converts CMP-Neu5Ac to CMP-Neu5Gc. However, Neu5Gc is metabolically incorporated into human tissues from dietary sources (particularly red meat) and detected at even higher levels in some human cancers.

The presence of anti-Neu5Gc antibodies in the human body suggests that antigen-antibody interactions involving Neu5Gc may contribute to chronic inflammation and the increased incidence of diet-related carcinomas and other diseases.

N-glycolylneuraminic acid (Neu5Gc) is a non-human sialic acid capable of potentiating cancer and inflammation in the human body. This concern is relevant to high consumption of red meat (beef, pork, lamb) as a dietary source of sialic acid, since these foods primarily contain Neu5Gc.

Infant formulas contain a low level of sialic acid consisting of both Neu5Ac and N-glycolylneuraminic acid (Neu5Gc). Neu5Gc is implicated in some human inflammatory diseases.

8.2 Pathogen Exploitation of Sialic Acid Receptors

Select human pathogenic microbes have evolved to express this human sialic acid epitope on their own cellular surface to evade host immune surveillance and clearance. For example, group B streptococcus (GBS), a common cause of sepsis in human newborns, presents terminal α2,3-linked sialic acid on its capsular polysaccharide to bind Siglecs expressed by neutrophils, macrophages, and platelets and block immune activation.

Several eukaryotic pathogens also employ sialic acid recognition as part of interactions with hosts (e.g., the falciparum malarial merozoite). A bacterial SubAb toxin selectively recognizes ligands bearing the Neu5Gc sialic acid.

8.3 Polysialic Acid and Neuropsychiatric Considerations

Post-mortem and genetic evidence suggests that dysregulation of polySia-NCAM is involved in schizophrenia. In a study enrolling 45 patients diagnosed with schizophrenia and 45 healthy individuals, polySia-NCAM serum levels were found to be increased in schizophrenia patients, independently of antipsychotic treatment, and were associated with negative symptoms, blunted affect, and declarative memory impairment. This suggests that abnormal sialic acid metabolism, rather than supplementation, may itself be a pathological variable in some psychiatric conditions.

8.4 Bioavailability Limitations in Supplement Formulations

The application of sialic acid is hindered by its inherent limitations, including poor skin permeability, rapid degradation, and low bioavailability in conventional formulations. This concern equally applies to oral supplemental forms, where the bioavailability and tissue incorporation of exogenous free Neu5Ac remains an active research question.

8.5 Overall Safety Profile

Major recent research findings on sialic acid have demonstrated the importance and advantages of this bioactive compound in human nutrition and health development, particularly in brain development, immune-enhancing, anti-hypertensive, anticancer, and skin-whitening properties. Current evidence suggests that humans require a sialic acid-rich diet as an important micronutrient. Therefore, sialic acid can be regarded as a valuable compound crucial for development and biological functions, thus having high potential to be applied as a functional food or supplement in various industries.

No formal upper tolerable intake levels or maximum safe supplemental doses for isolated sialic acid (Neu5Ac) in humans have been established by major regulatory bodies such as the FDA, EFSA, or WHO as of the time of this article. The form of sialic acid consumed — whether Neu5Ac (human-compatible) or Neu5Gc (derived from red meat) — has distinct safety implications, and high consumption of Neu5Gc via red meat has been flagged in the research literature as a potential contributor to chronic inflammation and cancer risk.

References

Health Conditions

Health conditions that Sialic acid may help support.

No conditions available.

Body Systems

Body systems that Sialic acid may help support.

No body systems available.